Masawa

Masawa is an impact-focused early-stage venture firm with a thesis centered on mental wellness and the broader nature-of-work and human-flourishing categories. Stage focus is seed and Series A, with checks plausibly in the $500k to $2M range and a willingness to syndicate alongside larger leads. Healthcare exposure is concentrated specifically in mental health, behavioral health, and workplace wellbeing rather than therapeutics, devices, or general digital health. Physician founders building mental and behavioral health platforms, particularly those with measurable outcomes and a credible commercial path through employers, payers, or providers, are the natural fit. Founders building anything outside the mental wellness category, or anyone building a pure-software platform without an outcome story, should pitch a different fund. Geographic posture is global, with comfort in North American and European deals and an explicit interest in companies that meet impact standards. The realistic entry path is a warm introduction from an impact ecosystem operator, an existing portfolio founder, or a mental health network advisor; founders can also engage through the firm’s published process, but referred deals receive faster diligence. Founders should arrive with outcome data, a clear theory of change, and a defended commercial model. Treat Masawa as a thesis-aligned mental health specialist that brings real diligence rigor and category fluency rather than a generalist option.